Lushang Health Industry Development Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
March 26, 2021 at 08:08 am
Share
Lushang Health Industry Development Co.,Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was CNY 13,615.482 million compared to CNY 10,289.206 million a year ago. Operating income was CNY 875.403 million compared to CNY 574.154 million a year ago. Net income was CNY 638.669 million compared to CNY 344.508 million a year ago. Basic earnings per share from continuing operations was CNY 0.64 compared to CNY 0.34 a year ago. Diluted earnings per share from continuing operations was CNY 0.63 compared to CNY 0.34 a year ago.
Lushang Freda Pharmaceutical Co Ltd is a China-based company mainly engaged in the manufacture and sale of pharmaceuticals and cosmetics. In terms of medicine, the Company is committed to the research and development, production and sales of Chinese patent medicines, chemical medicines, and health foods. Its products cover five fields: orthopedics, gynecology, internal medicine, ophthalmology, and pediatrics. The Company's cosmetic products involve aroma therapy, aroma skin care, aroma health care, aroma health care and other fields. In terms of raw materials, derivative products, and additives, the Company is mainly engaged in the production of hyaluronic acid raw materials.
LUSHANG FREDA PHARMACEUTICAL CO.,LTD. 
